Study of familial Parkinson’s disease in Russia, Uzbekistan, and Zambia

Objective: The aims of this study were (A) to determine inheritance patterns of familial Parkinson’s disease in three different geographical areas (Russia, Uzbekistan, and Zambia); (B) compare clinical characteristics of familial with sporadic Parkinson’s disease; and (C) assess whether there were e...

Full description

Saved in:
Bibliographic Details
Published inPostgraduate medical journal Vol. 81; no. 952; pp. 117 - 121
Main Authors Atadzhanov, M, Zumla, A, Mwaba, P
Format Journal Article
LanguageEnglish
Published London The Fellowship of Postgraduate Medicine 01.02.2005
BMJ
Oxford University Press
BMJ Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective: The aims of this study were (A) to determine inheritance patterns of familial Parkinson’s disease in three different geographical areas (Russia, Uzbekistan, and Zambia); (B) compare clinical characteristics of familial with sporadic Parkinson’s disease; and (C) assess whether there were ethnic differences in clinical manifestations of the disease. Methods: Fifty two index cases of familial Parkinson’s disease in Moscow, 55 in Tashkent, and 27 in Lusaka were selected on the basis of the typical clinical features of Parkinson’s disease with a familial history. The sex ratio, transmission patterns, and segregation ratio were determined by pedigree analysis. Results: Familial Parkinson’s disease was found in all three countries (30 families in Russia, 12 in Uzbekistan, and seven in Zambia), and appeared more common in Russia. Both autosomal dominant and autosomal recessive patterns of inheritance were seen, but autosomal dominance was more common in all countries. Conclusions: In all three countries men have a higher risk of developing Parkinson’s disease than women and there are ethnic differences in clinical manifestations of the disease. The onset of both familial and sporadic Parkinson’s disease in Zambian patients occurs at a younger age and is associated with slow progression and a benign course, and generally responds well to levodopa treatment.
Bibliography:ark:/67375/NVC-5FFGJNNM-B
local:0810117
PMID:15701745
href:postgradmedj-81-117.pdf
Correspondence to:
 Professor Masharip Atadzhanov
 Department of Medicine, University of Zambia School of Medicine, PO Box 50110, University Teaching Hospital, Lusaka, Zambia; masharip@yahoo.com
istex:753DADF407ED9E63124CDD49219BCCBF48A1D175
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0032-5473
1469-0756
DOI:10.1136/pgmj.2004.018705